Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP-304 in Chronic Idiopathic Constipation
NCT01053962Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Mar 2010
- Primary completion
- Aug 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of plecanatide in chronic idiopathic constipation (CIC) (5 arms), sponsored by Valeant Pharmaceuticals. Primary endpoint: Number of Participants With Adverse Events at 21 days. Started Mar 2010; status: completed.
02
Drugs
plecanatide
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01053962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01053962.